TOBRAMYCIN SULFATE Drug Patent Profile
✉ Email this page to a colleague
When do Tobramycin Sulfate patents expire, and what generic alternatives are available?
Tobramycin Sulfate is a drug marketed by Apothecon, Baxter Hlthcare Corp, Epic Pharma Llc, Eugia Pharma, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma, Hospira, Igi Labs Inc, Mylan Labs Ltd, Slate Run Pharma, Teva Pharms Usa, Watson Labs Inc, Xellia Pharms Aps, and Xgen Pharms. and is included in thirty-two NDAs.
The generic ingredient in TOBRAMYCIN SULFATE is tobramycin sulfate. There are eighteen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the tobramycin sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tobramycin Sulfate
A generic version of TOBRAMYCIN SULFATE was approved as tobramycin sulfate by HIKMA on April 26th, 1991.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TOBRAMYCIN SULFATE?
- What are the global sales for TOBRAMYCIN SULFATE?
- What is Average Wholesale Price for TOBRAMYCIN SULFATE?
Summary for TOBRAMYCIN SULFATE
| US Patents: | 0 |
| Applicants: | 15 |
| NDAs: | 32 |
| Finished Product Suppliers / Packagers: | 11 |
| Raw Ingredient (Bulk) Api Vendors: | 105 |
| Clinical Trials: | 5 |
| Patent Applications: | 4,190 |
| DailyMed Link: | TOBRAMYCIN SULFATE at DailyMed |
Recent Clinical Trials for TOBRAMYCIN SULFATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Madonna Magdy Fahmy | Early Phase 1 |
| Osteal Therapeutics, Inc. | Phase 2 |
| Joint Purification Systems | Phase 2 |
Pharmacology for TOBRAMYCIN SULFATE
| Drug Class | Aminoglycoside Antibacterial |
Anatomical Therapeutic Chemical (ATC) Classes for TOBRAMYCIN SULFATE
US Patents and Regulatory Information for TOBRAMYCIN SULFATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Xgen Pharms | TOBRAMYCIN SULFATE | tobramycin sulfate | INJECTABLE;INJECTION | 065013-001 | Aug 17, 2001 | AP | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Teva Pharms Usa | TOBRAMYCIN SULFATE | tobramycin sulfate | INJECTABLE;INJECTION | 063100-001 | Jan 30, 1992 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Fresenius Kabi Usa | TOBRAMYCIN SULFATE (PHARMACY BULK) | tobramycin sulfate | INJECTABLE;INJECTION | 065120-001 | Nov 29, 2002 | AP | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Watson Labs Inc | TOBRAMYCIN SULFATE | tobramycin sulfate | INJECTABLE;INJECTION | 062945-001 | Aug 9, 1989 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
